A carregar...

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation

Pharmacologic augmentation of endogenous cannabinoid (eCB) signaling is an emerging therapeutic approach for the treatment of a broad range of pathophysiological conditions. Thus far, pharmacological approaches have focused on inhibition of canonical eCB inactivation pathways, fatty acid amide hydro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hermanson, Daniel J., Gamble-George, Joyonna C., Marnett, Lawrence J., Patel, Sachin
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074568/
https://ncbi.nlm.nih.gov/pubmed/24845457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2014.04.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!